What endpoints should be used for clinical studies in acute kidney injury?

Intensive Care Med. 2017 Jun;43(6):901-903. doi: 10.1007/s00134-017-4732-1. Epub 2017 Mar 2.

Authors

John A Kellum¹, Alexander Zarbock², Mitra K Nadim³

Affiliations

¹ Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, 604, Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA. kellumja@upmc.edu.
² Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Münster, Germany.
³ Division of Nephrology and Hypertension, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

PMID: 28255614
DOI: 10.1007/s00134-017-4732-1

No abstract available

MeSH terms

Acute Kidney Injury* / diagnosis
Acute Kidney Injury* / mortality
Acute Kidney Injury* / prevention & control
Acute Kidney Injury* / therapy
Biomarkers / blood
Biomarkers / urine
Clinical Studies as Topic*
Disease Progression
Endpoint Determination*
Humans
Quality of Life
Registries
Risk Factors
Treatment Outcome

Substances

Biomarkers